login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INHIBRX BIOSCIENCES INC (INBX) Stock News
USA
- NASDAQ:INBX -
US45720N1037
-
Common Stock
81.66
USD
+3.15 (+4.01%)
Last: 10/31/2025, 8:00:02 PM
80.1
USD
-1.56 (-1.91%)
After Hours:
10/31/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INBX Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Chartmill
- Mentions:
SDA
RNA
CMBM
ADTX
...
Unusual volume stocks in Thursday's session
5 days ago - By: Chartmill
- Mentions:
SOHO
ITGR
BYND
BRTX
...
The trading volume of these stocks is deviating from the norm in today's session.
7 days ago - By: Benzinga
- Mentions:
F
NUE
WM
KDP
US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone
9 days ago - By: Chartmill
- Mentions:
MOFG
GSIT
YGMZ
NEGG
...
Here are the top movers in Friday's session.
9 days ago - By: Benzinga
- Mentions:
NEM
NSC
BKR
SSNC
...
Stocks Soar To Records After Weak Inflation, Ford Jumps 10%: What's Moving Markets Friday?
9 days ago - By: Chartmill
- Mentions:
FMFC
MOFG
YGMZ
LAZR
...
What's going on in today's session
10 days ago - By: Chartmill
- Mentions:
DECK
MOFG
XFOR
QLGN
...
Which stocks are gapping on Friday?
10 days ago - By: Chartmill
- Mentions:
DECK
MOFG
AMBI
ASNS
...
Get insights into the top gainers and losers of Friday's pre-market session.
10 days ago - By: Stocktwits
- Mentions:
VTWO
IWV
Why Is INBX Stock Rising Today?
10 days ago - By: Chartmill
- Mentions:
DECK
CYH
FIX
ASX
...
Get insights into the top gainers and losers of Thursday's after-hours session.
10 days ago - By: Inhibrx Biosciences, Inc.
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
11 days ago - By: Inhibrx Biosciences, Inc.
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
3 months ago - By: The Motley Fool
Inhibrx Biosciences Beats Earnings
3 months ago - By: Inhibrx Biosciences, Inc.
Inhibrx Reports Second Quarter 2025 Financial Results
6 months ago - By: Inhibrx Biosciences, Inc.
Inhibrx Reports First Quarter 2025 Financial Results
7 months ago - By: Inhibrx Biosciences, Inc.
Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President
8 months ago - By: Inhibrx Biosciences, Inc.
Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results
10 months ago - By: Inhibrx Biosciences, Inc.
Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
10 months ago - By: Inhibrx Biosciences, Inc.
Inhibrx Biosciences Announces Loan Agreement with Oxford Finance
a year ago - By: Inhibrx Biosciences, Inc.
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
a year ago - By: Inhibrx Biosciences, Inc.
Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
Please enable JavaScript to continue using this application.